Elisa Rumi

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 44

Top Venues

Blood

American journal of hematology

Leukemia

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Richard Grunwald, Ellen K Ritchie, Elisa Rumi, Albert Assad, J E Hamer-Maansson, Jingbo Yu, Tricia Kalafut, Evan Braunstein, Francesco Passamonti
Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched-cohort analysis. EJHaem 5 (4) (2024)
Michael Richard Grunwald, Ellen K Ritchie, Elisa Rumi, Albert Assad, J E Hamer-Maansson, Jingbo Yu, Tricia Kalafut, Evan Braunstein, Francesco Passamonti
Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched-cohort analysis. EJHaem 5 (4) (2024)
Alessandra Carobbio, Alessandro Maria Vannucchi, Elisa Rumi, Valerio De Stefano, Alessandro Rambaldi, Giuseppe Carli, Maria Luigia Randi, Heinz Gisslinger, Francesco Passamonti, Juergen Thiele, Naseema Gangat, Ayalew Tefferi, Tiziano Barbui
Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach. Blood cancer journal 13 (1) (2023)
Giacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, Francesco Mannelli, Valerio De Stefano, Marco Ruggeri, Elena Maria Elli, Roberta Zanotti, Oscar Borsani, Irene Bertozzi, Andrea Duminuco, Silvia Betti, Giuseppe Carli, Fabrizio Cavalca, Ilaria Tanasi, Elisa Rumi, Maria L Randi, Bruno Garibaldi, Giuseppe Gaetano Loscocco, Paola Guglielmelli, Alessandro M Vannucchi
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project. Cancer medicine (2023)
Jelena D M Feenstra, Roland Jäger, Fiorella Schischlik, Daniel Ivanov, Gregor Eisenwort, Elisa Rumi, Michael Schuster, Bettina Gisslinger, Sigrid Machherndl-Spandl, Peter Bettelheim, Maria-Theresa Krauth, Felix Keil, Christoph Bock, Mario Cazzola, Heinz Gisslinger, Robert Kralovics, Peter Valent
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms. American journal of hematology 97 (4) (2022)
Ilaria Carola Casetti, Oscar Borsani, Elisa Rumi
COVID-19 in Patients with Hematologic Diseases. Biomedicines 10 (12) (2022)
Jonas Samuel Jutzi, Anna E Marneth, Michele Ciboddo, Angel Guerra-Moreno, María José Jiménez-Santos, Anastasia Kosmidou, James W Dressman, Hongyan Liang, Rebecca Hamel, Patricia Lozano, Elisa Rumi, John G Doench, Jason Gotlib, Anandi Krishnan, Shannon Elf, Fátima Al-Shahrour, Ann Mullally
Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood 140 (11) (2022)
Marco Salvini, Camilla Damonte, Lorenzo Mortara, Fabrizio Maggi, Antonino Bruno, Giacomo Pellegrini, Barbara Mora, Marco Brociner, Alessia Ingrassia, Roberta Mattarucchi, Benedetta Bianchi, Davide Sirocchi, Stefania Agnoli, Elisa Rumi, Michele Merli, Alessandro Fossati, Susanna Bassi, Raffaella Bombelli, Matteo Gallazzi, Oscar Borsani, Andreina Baj, Matteo Franchi, Paolo A Grossi, Francesco Passamonti
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients. American journal of hematology 97 (8) (2022)
Christian Pecquet, Nicolas Papadopoulos, Thomas Balligand, Ilyas Chachoua, Amandine Tisserand, Gaëlle Vertenoeil, Audrey Nédélec, Didier Vertommen, Anita Roy, Caroline Marty, Harini Nivarthi, Jean-Philippe Defour, Mira El-Khoury, Eva Hug, Andrea Majoros, Erica Xu, Oleh Zagrijtschuk, Tudor Emanuel Fertig, Daciana S Marta, Heinz Gisslinger, Bettina Gisslinger, Martin Schalling, Ilaria Carola Casetti, Elisa Rumi, Daniela Pietra, Chiara Cavalloni, Luca Arcaini, Mario Cazzola, Norio Komatsu, Yoshihiko Kihara, Yoshitaka Sunami, Yoko Edahiro, Marito Araki, Roman Lesyk, Veronika Buxhofer-Ausch, Sonja Heibl, Florence Pasquier, Isabelle Plo, William Vainchenker, Robert Kralovics, Stefan N Constantinescu
Secreted Mutant Calreticulins As Rogue Cytokines in Myeloproliferative Neoplasms. Blood (2022)
Juan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz, Michele Ciboddo, Harrison S Greenbaum, Nicole S Arellano, Deborah Rodriguez, Maria Evers, Althea Bock-Hughes, Chenyu Liu, Quinn Smith, Julian Lutze, Julian Baumeister, Milena Kalmer, Kathrin Olschok, Benjamin Nicholson, Diane Silva, Luke Maxwell, Jonathan Dowgielewicz, Elisa Rumi, Daniela Pietra, Ilaria Carola Casetti, Silvia Catricala, Steffen Koschmieder, Sandeep K Gurbuxani, Rebekka K Schneider, Scott A Oakes, Shannon E Elf
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms. Blood cancer discovery 3 (4) (2022)
Oscar Borsani, Takaki Asano, Bertrand Boisson, Sara Fraticelli, Marta Braschi-Amirfarzan, Daniela Pietra, Ilaria Carola Casetti, Daniele Vanni, Chiara Trotti, Alessandro Borghesi, Jean-Laurent Casanova, Luca Arcaini, Elisa Rumi
Isolated congenital asplenia: An overlooked cause of thrombocytosis. American journal of hematology 97 (8) (2022)
Daniele Vanni, Oscar Borsani, Yasuhito Nannya, Emanuela Sant'Antonio, Chiara Trotti, Ilaria Carola Casetti, Daniela Pietra, Anna Gallì, Silvia Zibellini, Virginia Valeria Ferretti, Luca Malcovati, Seishi Ogawa, Luca Arcaini, Elisa Rumi
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms. EJHaem 3 (2) (2022)
Ilaria Carola Casetti, Oscar Borsani, Elisa Rumi
COVID-19 in Patients with Hematologic Diseases. Biomedicines 10 (12) (2022)
Margherita Maffioli, Barbara Mora, Somedeb Ball, Alessandra Iurlo, Elena Maria Elli, Maria Chiara Finazzi, Nicola Polverelli, Elisa Rumi, Marianna Caramella, Maria Cristina Carraro, Mariella D'Adda, Alfredo Molteni, Cinzia Sissa, Francesca Lunghi, Alessandro Vismara, Marta Ubezio, Anna Guidetti, Sabrina Caberlon, Michela Anghilieri, Rami S Komrokji, Daniele Cattaneo, Matteo Giovanni Della Porta, Toni Giorgino, Lorenza Bertù, Marco Brociner, Andrew T Kuykendall, Francesco Passamonti
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis. Blood advances 6 (6) (2022)
Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Greta Carioli, Marta Anna Sobas, Elena Maria Elli, Elisa Rumi, Valerio De Stefano, Francesca Lunghi, Monia Marchetti, Rosa Daffini, Mercedes Gasior Kabat, Beatriz Cuevas, Maria Laura Fox, Marcio Miguel Andrade-Campos, Francesca Palandri, Paola Guglielmelli, Giulia Benevolo, Claire Harrison, Maria Angeles Foncillas, Massimiliano Bonifacio, Alberto Alvarez-Larran, Jean-Jacques Kiladjian, Estefanía Bolaños Calderón, Andrea Patriarca, Keina Susana Quiroz Cervantes, Martin Griessammer, J Valentín García-Gutiérrez, Alberto Marin Sanchez, Elena Magro Mazo, Marco Ruggeri, Juan Carlos Carlos Hernández-Boluda, Santiago Osorio, Gonzalo Carreno-Tarragona, Miguel Sagues Serrano, Rajko Kusec, Begona Navas Elorza, Anna Angona, Blanca Xicoy Cirici, Emma Lopez Abadia, Steffen Koschmieder, Daniele Cattaneo, Cristina Bucelli, Edyta Cichocka, Anna Masternak Kulikowska de Nałęcz, Fabrizio Cavalca, Oscar Borsani, Silvia Betti, Lina Benajiba, Marta Bellini, Natalia Curto-Garcia, Alessandro Rambaldi, Alessandro Maria Vannucchi
Second versus first wave of COVID-19 in patients with MPN. Leukemia 36 (3) (2022)
Oscar Borsani, Paul Bastard, Jérémie Rosain, Adrian Gervais, Emanuela Sant'Antonio, Daniele Vanni, Ilaria Carola Casetti, Daniela Pietra, Chiara Trotti, Silvia Catricalà, Virginia Valeria Ferretti, Luca Malcovati, Luca Arcaini, Jean-Laurent Casanova, Alessandro Borghesi, Elisa Rumi
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms. Blood 139 (17) (2022)
Barbara Mora, Paola Guglielmelli, Andrew Kuykendall, Elisa Rumi, Margherita Maffioli, Francesca Palandri, Valerio De Stefano, Marianna Caramella, Silvia Salmoiraghi, Jean-Jacques Kiladjian, Jason Gotlib, Alessandra Iurlo, Francisco Cervantes, Marco Ruggeri, Richard T Silver, Francesco Albano, Giulia Benevolo, David Morrall Ross, Matteo G Della Porta, Timothy Devos, Giada Rotunno, Rami S Komrokji, Ilaria C Casetti, Michele Merli, Marco Brociner, Domenica Caramazza, Giuseppe Auteri, Tiziano Barbui, Daniele Cattaneo, Lorenza Bertù, Luca Arcaini, Alessandro M Vannucchi, Francesco Passamonti
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients. Leukemia 36 (10) (2022)
Tiziano Barbui, Alessandro Maria Vannucchi, Alberto Alvarez-Larran, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Alberto Ferrari, Giuseppe Rossi, Elena Elli, Marcio Miguel Andrade-Campos, Mercedes Gasior Kabat, Jean-Jaques Kiladjian, Francesca Palandri, Giulia Benevolo, Valentin Garcia-Gutierrez, Maria Laura Fox, Maria Angeles Foncillas, Carmen Montoya Morcillo, Elisa Rumi, Santiago Osorio, Petros Papadopoulos, Massimiliano Bonifacio, Keina Susana Quiroz Cervantes, Miguel Sagues Serrano, Gonzalo Carreno-Tarragona, Marta Anna Sobas, Francesca Lunghi, Andrea Patriarca, Begona Navas Elorza, Anna Angona, Elena Magro Mazo, Steffen Koschmieder, Marco Ruggeri, Beatriz Cuevas, Juan Carlos Carlos Hernández-Boluda, Emma Lopez Abadia, Blanca Xicoy Cirici, Paola Guglielmelli, Marta Garrote, Daniele Cattaneo, Rosa Daffini, Fabrizio Cavalca, Beatriz Bellosillo, Lina Benajiba, Natalia Curto-Garcia, Marta Bellini, Silvia Betti, Valerio De Stefano, Claire Harrison, Alessandro Rambaldi
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. Leukemia 35 (2) (2021)
Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Giuseppe Rossi, Claire Harrison, Alberto Alvarez-Larran, Elena Maria Elli, Jean-Jaques Kiladjian, Mercedes Gasior Kabat, Alberto Marin Sanchez, Francesca Palandri, Marcio Miguel Andrade-Campos, Alessandro Maria Vannucchi, Gonzalo Carreno-Tarragona, Petros Papadopoulos, Keina Susana Quiroz Cervantes, Maria Angeles Foncillas, Maria Laura Fox, Miguel Sagues Serrano, Elisa Rumi, Santiago Osorio, Giulia Benevolo, Andrea Patriarca, Begona Navas Elorza, Valentin Garcia-Gutierrez, Elena Magro Mazo, Francesca Lunghi, Massimiliano Bonifacio, Valerio De Stefano, Juan Carlos Carlos Hernández-Boluda, Emma Lopez Abadia, Anna Angona, Blanca Xicoy Cirici, Marco Ruggeri, Steffen Koschmieder, Marta Anna Sobas, Beatriz Cuevas, Daniele Cattaneo, Rosa Daffini, Marta Bellini, Natalia Curto-Garcia, Marta Garrote, Fabrizio Cavalca, Lina Benajiba, Beatriz Bellosillo, Paola Guglielmelli, Oscar Borsani, Silvia Betti, Silvia Salmoiraghi, Alessandro Rambaldi
Long-term follow-up of recovered MPN patients with COVID-19. Blood cancer journal 11 (6) (2021)
Chiara Trotti, Emanuela Sant'Antonio, Daniele Vanni, Ilaria Carola Casetti, Oscar Borsani, Daniela Pietra, Virginia Valeria Ferretti, Cesare Astori, Luca Arcaini, Elisa Rumi
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis. Hematological oncology 39 (4) (2021)
Paola Guglielmelli, Arianna Ghirardi, Alessandra Carobbio, Arianna Masciulli, Chiara Maccari, Barbara Mora, Elisa Rumi, Ana Triguero, Maria Chiara Finazzi, Helna Pettersson, Chiara Paoli, Francesco Mannelli, Daniele Vanni, Alessandro Rambaldi, Francesco Passamonti, Alberto Alvarez-Larran, Bjorn I Andreasson, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of ERNEST Study. Blood advances (2021)
Tiziano Barbui, Valerio De Stefano, Alberto Alvarez-Larran, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Alberto Ferrari, Valeria Cancelli, Elena Maria Elli, Marcio Miguel Andrade-Campos, Mercedes Gasior Kabat, Jean-Jaques Kiladjian, Francesca Palandri, Giulia Benevolo, J Valentín García-Gutiérrez, Maria Laura Fox, Maria Angeles Foncillas, Carmen Montoya Morcillo, Elisa Rumi, Santiago Osorio, Petros Papadopoulos, Massimiliano Bonifacio, Keina Susana Quiroz Cervantes, Miguel Sagues Serrano, Gonzalo Carreno-Tarragona, Marta Anna Sobas, Francesca Lunghi, Andrea Patriarca, Begoña Navas Elorza, Anna Angona, Elena Magro Mazo, Steffen Koschmieder, Giuseppe Carli, Beatriz Cuevas, Juan Carlos Carlos Hernández-Boluda, Emma Lopez Abadia, Blanca Xicoy Cirici, Paola Guglielmelli, Marta Garrote, Daniele Cattaneo, Rosa Daffini, Fabrizio Cavalca, Beatriz Bellosillo, Lina Benajiba, Natalia Curto-Garcia, Marta Bellini, Silvia Betti, Claire Harrison, Alessandro Rambaldi, Alessandro Maria Vannucchi
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. Blood cancer journal 11 (2) (2021)
Alessandra Carobbio, Paola Guglielmelli, Elisa Rumi, Chiara Cavalloni, Valerio De Stefano, Silvia Betti, Alessandro Rambaldi, Maria Chiara Finazzi, Juergen Thiele, Alessandro M Vannucchi, Ayalew Tefferi, Tiziano Barbui
A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis. Blood cancer journal 10 (10) (2020)
Barbara Mora, Claudia Siracusa, Elisa Rumi, Margherita Maffioli, Ilaria Carola Casetti, Daniela Barraco, Michele Merli, Marianna Rossi, Marta Ubezio, Raffaella Accetta, Laura Libera, Daniela Pietra, Chiara Trotti, Silvia Uccella, Francesco Pallotti, Rosario Casalone, Lorenza Bertù, Luca Arcaini, Matteo Giovanni Della Porta, Francesco Passamonti
Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis. Leukemia 35 (5) (2020)
Elisa Rumi, Chiara Trotti, Daniele Vanni, Ilaria Carola Casetti, Daniela Pietra, Emanuela Sant'Antonio
The Genetic Basis of Primary Myelofibrosis and Its Clinical Relevance. International journal of molecular sciences 21 (23) (2020)
Elisa Rumi, Emanuela Sant'Antonio, Chiara Cavalloni, Giuditta Comolli, Virginia Valeria Ferretti, Irene Cassaniti, Daniela Pietra, Chiara Trotti, Michele Ciboddo, Milena Furione, Daniele Vanni, Ilaria Carola Casetti, Cristina Favaron, Fausto Baldanti, Luca Arcaini, Mario Cazzola
Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib. Hematological oncology 38 (4) (2020)
Gabriele Todisco, Maria Creignou, Anna Galli, Paola Guglielmelli, Elisa Rumi, Marco Roncador, Ettore Rizzo, Yasuhito Nannya, Daniela Pietra, Chiara Elena, Elisa Bono, Elisabetta Molteni, Vittorio Rosti, Silvia Catricalá, Martina Sarchi, Marios Dimitriou, Johanna Ungerstedt, Alessandro Maria Vannucchi, Eva Hellström-Lindberg, Seishi Ogawa, Mario Cazzola, Luca Malcovati
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms. Leukemia 35 (8) (2020)
Paola Guglielmelli, Alessandra Carobbio, Elisa Rumi, Valerio De Stefano, Lara Mannelli, Francesco Mannelli, Giada Rotunno, Giacomo Coltro, Silvia Betti, Chiara Cavalloni, Maria Chiara Finazzi, Juergen Thiele, Mario Cazzola, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis. Blood cancer journal 10 (2) (2020)
Emanuela Sant'Antonio, Massimiliano Bonifacio, Massimo Breccia, Elisa Rumi
A journey through infectious risk associated with ruxolitinib. British journal of haematology 187 (3) (2019)
Fiorella Schischlik, Roland Jäger, Felix Rosebrock, Eva Hug, Michael K Schuster, Raimund Holly, Elisabeth Fuchs, Jelena D M Feenstra, Edith Bogner, Bettina Gisslinger, Martin Schalling, Elisa Rumi, Daniela Pietra, Gottfried Fischer, Ingrid Fae, Loan Vulliard, J Formula See Text Rg Menche, Torsten Haferlach, Manja Meggendorfer, Anna Stengel, Christoph Bock, Mario Cazzola, Heinz Gisslinger, Robert Kralovics
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms. Blood 134 (2) (2019)
Elisa Rumi, Claudia Baratè, Giulia Benevolo, Margherita Maffioli, Alessandra Ricco, Emanuela Sant'Antonio
Myeloproliferative and lymphoproliferative disorders: State of the art. Hematological oncology 38 (2) (2019)
Giada Rotunno, Carmela Mannarelli, Giada Brogi, Annalisa Pacilli, Francesca Gesullo, Francesco Mannelli, Sara Fiaccabrino, Benedetta Sordi, Chiara Paoli, Ilaria Marone, Elisa Rumi, Rossella Manfredini, Giovanni Barosi, Mario Cazzola, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Spectrum of ASXL1 mutations in primary myelofibrosis: prognostic impact of the ASXL1 p.G646Wfs*12 mutation. Blood 133 (26) (2019)
Elisa Rumi, Silvia Zibellini, Emanuela Boveri, Chiara Cavalloni, Roberta Riboni, Ilaria Carola Casetti, Michele Ciboddo, Chiara Trotti, Cristina Favaron, Daniela Pietra, Chiara Candido, Virginia Valeria Ferretti, Mario Cazzola, Luca Arcaini
Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms. American journal of hematology 94 (7) (2019)
Elisa Rumi, Mary F McMullin, Claire Harrison, Martin H Ellis, Merav Barzilai, Nadav Sarid, Ruben Mesa, Chiara Paoli, Anna Angona, Emanuela Sant'Antonio, Virginia V Ferretti, Chiara Cavalloni, Ilaria C Casetti, Chiara Trotti, Tiziano Barbui
Facing erythrocytosis: Results of an international physician survey. American journal of hematology 94 (9) (2019)
Elisa Rumi, Silvia Zibellini
JAK inhibitors and risk of B-cell lymphomas. Blood 133 (21) (2019)
Monia Marchetti, Arianna Ghirardi, Arianna Masciulli, Alessandra Carobbio, Francesca Palandri, Nicola Vianelli, Elena Maria Elli, Silvia Betti, Ambra Di Veroli, Alessandra Iurlo, Daniele Cattaneo, Guido Finazzi, Massimiliano Bonifacio, Luigi Scaffidi, Andrea Patriarca, Elisa Rumi, Ilaria Carola Casetti, Clemency Stephenson, Paola Guglielmelli, Elena Maria Elli, Miroslava Palova, Davide Rapezzi, Daniel Erez, Montse Gomez, Kai Wille, Manuel Perez-Encinas, Francesca Lunghi, Anna Angona, Maria Laura Fox, Eloise Beggiato, Giulia Benevolo, Giuseppe Carli, Rossella Cacciola, Mary Frances McMullin, Alessia Tieghi, Valle Recasens, Susanne Isfort, Fabrizio Pane, Valerio De Stefano, Martin Griesshammer, Alberto Alvarez-Larran, Alessandro Maria Vannucchi, Alessandro Rambaldi, Tiziano Barbui
Second cancers in MPN: Survival analysis from an international study. American journal of hematology 95 (3) (2019)
Tiziano Barbui, Arianna Ghirardi, Arianna Masciulli, Alessandra Carobbio, Francesca Palandri, Nicola Vianelli, Valerio De Stefano, Silvia Betti, Ambra Di Veroli, Alessandra Iurlo, Daniele Cattaneo, Federica Delaini, Massimiliano Bonifacio, Luigi Scaffidi, Andrea Patriarca, Elisa Rumi, Ilaria Carola Casetti, Clemency Stephenson, Paola Guglielmelli, Elena Maria Elli, Miroslava Palova, Laura Bertolotti, Daniel Erez, Montse Gomez, Kai Wille, Manuel Perez-Encinas, Francesca Lunghi, Anna Angona, Maria Laura Fox, Eloise Beggiato, Giulia Benevolo, Giuseppe Carli, Rossella Cacciola, Mary Frances McMullin, Alessia Tieghi, Valle Recasens, Monia Marchetti, Martin Griesshammer, Alberto Alvarez-Larran, Alessandro Maria Maria Vannucchi, Guido Finazzi
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. Leukemia 33 (8) (2019)
Emanuela Sant'Antonio, Paola Guglielmelli, Lisa Pieri, Massimo Primignani, Maria Luigia Randi, Claudia Santarossa, Elisa Rumi, Francisco Cervantes, Federica Delaini, Alessandra Carobbio, Silvia Betti, Elena Rossi, Noa Lavi, Claire N Harrison, Natalia Curto-Garcia, Heinz Gisslinger, Bettina Gisslinger, Giorgina Specchia, Alessandra Ricco, Nicola Vianelli, Nicola Polverelli, Maya Koren-Michowitz, Marco Ruggeri, Francois Girodon, Martin Ellis, Alessandra Iurlo, Francesco Mannelli, Lara Mannelli, Benedetta Sordi, Giuseppe Gaetano Loscocco, Mario Cazzola, Valerio De Stefano, Tiziano Barbui, Ayalew Tefferi, Alessandro Maria Maria Vannucchi
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases. American journal of hematology 95 (2) (2019)
Barbara Mora, Paola Guglielmelli, Elisa Rumi, Margherita Maffioli, Daniela Barraco, Alessandro Rambaldi, Marianna Caramella, Rami S Komrokji, Jean-Jacques Kiladjian, Jason Gotlib, Alessandra Iurlo, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T Silver, Francesco Albano, Giulia Benevolo, Chiara Cavalloni, Silvia Uccella, Raffaella Accetta, Claudia Siracusa, Stefania Agnoli, Michele Merli, Tiziano Barbui, Lorenza Bertù, Mario Cazzola, Alessandro Maria Maria Vannucchi, Francesco Passamonti
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. American journal of hematology 95 (1) (2019)
Elisa Rumi, Mario Cazzola
Advances in understanding the pathogenesis of familial myeloproliferative neoplasms. British journal of haematology 178 (5) (2017)
Elisa Rumi, Ashot S Harutyunyan, Daniela Pietra, Jelena D Milosevic Feenstra, Chiara Cavalloni, Elisa Roncoroni, Ilaria Casetti, Marta Bellini, Chiara Milanesi, Maria C Renna, Manuel Gotti, Cesare Astori, Robert Kralovics, Mario Cazzola
LNK mutations in familial myeloproliferative neoplasms. Blood 128 (1) (2016)
Elisa Rumi, Mario Cazzola
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood 129 (6) (2016)
Elisa Rumi, Mario Cazzola
How I treat essential thrombocythemia. Blood 128 (20) (2016)
Elisa Rumi, Jelena D Milosevic, Dominik Selleslag, Ilaria Casetti, Els Lierman, Daniela Pietra, Chiara Cavalloni, Marta Bellini, Chiara Milanesi, Irene Dambruoso, Cesare Astori, Robert Kralovics, Peter Vandenberghe, Mario Cazzola
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene. Annals of hematology 94 (11) (2015)

Elisa Rumi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Elisa Rumi